Popular Articles
Cellulite Cream

White House Appeals To Shared Responsibility For Tackling Flu, Including H1N1, This Fall
White House officials said today that getting ready for the flu in the fall, whether it is seasonal flu or the ongoing H1N1 swine flu outbreak, is a
generic viagra online
Fighting Drug-Resistant Flu Viruses
Amid reports that swine flu viruses are developing the ability to shrug off existing antiviral drugs, scientists in Japan are reporting a first-of-its kind discovery that could foster a new genre of antivirals that sidestep resistance problems, according to an article scheduled for the July 23 issue of the ACS" Journal of the Medicinal Chemistry, a bi-weekly publication.
News of the day
Health Reform Should 'Permanently Exclude' Funding Of Abortion Coverage, Family Research President Perkins Writes
"No matter what form of health care reform emerges from the current debates and discussion," Congress should include a "provision to the legislation to permanently exclude abortion from taxpayer-funded health care or health insurance," Family Research Council President Tony Perkins writes in a Politico opinion piece. Although some argue that the government "cannot or should not restrict benefits when it purchases insurance, the same way it does when reimbursing directly for medical procedures," that argument "already failed when it came up in the 1990s in the context of Medicaid managed care plans," Perkins writes, adding that the Hyde Amendment was "revised to cover them, as well." There also are arguments in Congress that "if people can opt for private health insurance that funds abortion and receive a tax break for their purchase of such insurance, then poor people dependent on direct government payments for their health insurance cannot be denied similar coverage," according to Perkins. However, "this presumes that there is no difference between what people may do with their own money and what they may do with the taxpayers" money," Perkins writes, adding that such an argument "makes sense only if we assume it"s all the government"s money in the end" (Perkins, Politico, 7/28).
Cardiovascular

Warning Issued Over Proposed Drug Company Promotion Of Medicines To Public, UK

Drug companies may exploit new rules to promote their products to the public but present it as mere provision of information, according to an editorial published this week in the Drug and Therapeutics Bulletin (DTB). Direct advertising of prescription-only medicines to the public is currently not allowed in the European Union (EU), but this position may be undermined by proposals from the European Commission (EC). The proposals, if agreed, would allow drug companies new opportunities to present the public with information about prescription-only medicine through the internet or yet-to-be-defined "health-related publications." The DTB editorial is concerned about the proposals, which it suggests would permit direct advertising to the public in spite of the EU-wide ban. It is proposed that each EU member state would ensure the companies providing the information were monitored and this could involve self-regulation by the companies. "A key concern about these ideas is the intrinsic difficulty in distinguishing between advertising of prescription-only medicines to the public (which would still be banned) and proactive provision of non-promotional information about such products," says the editorial. The UK medicines regulator, the Medicines and Healthcare products Regulatory Agency, is currently carrying out a public consultation on this issue - due to finish on August 14 - but supports the principle of allowing the pharmaceutical industry to give patients more information about medicines. DTB, however, cites the negative experience in the US with direct to consumer advertising, where "infringements of rules on information provision have tended to be detected far too late and where there have been difficulties in imposing effective penalties." The editorial concludes: "We believe that acceptance of the EC"s proposals would permit public dissemination of promotional information about prescription-only medicines, masquerading as "information provision"." Given the obvious conflict of interests, DTB concludes, it would be naç¯ve to think that the pharmaceutical industry would provide independent and reliable information to allow people to make informed choices about treatment. "How to misinform patients." DTB 2009; doi 10.1136/dtb.2009.07.0027 Drug And Therapeutics Bulletin


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):